IFP Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

IFP Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,700	Closed	-$62K	–	4126
2016 Q4	$62K	Sell	1,700 -300	-15%	-$12K	﹤0.01%	1752
2016 Q3	$92K	Buy	2,000 +500	+33%	+$26.1K	﹤0.01%	1420
2016 Q2	$75K	Buy	+1,500	New	+$79.9K	﹤0.01%	1512
2016 Q1	–	Sell	-1,000	Closed	-$66K	–	3344
2015 Q4	$66K	Buy	+1,000	New	+$61.8K	﹤0.01%	1439

Other funds holding TEVA

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

UBP

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

BCM

Bourgeon Capital Management Darien, Connecticut $679M AUM 50.89% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

IFP Advisors's TEVA Position: Q2 2026 in Review

IFP Advisors increased its Teva Pharmaceuticals (TEVA) stake by 1.1% in Q2 2026, buying an estimated $51K and bringing the position to 143,876 shares worth $4.87M. The position accounts for 0.09% of the portfolio, ranked #257.

IFP Advisors first reported a position in TEVA in Q4 2015 and has held it in 42 quarters since. 141 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

IFP Advisors held 143,876 shares of Teva Pharmaceuticals worth $4.87M as of Q2 2026.
IFP Advisors bought 1,532 Teva Pharmaceuticals shares in Q2 2026, an estimated $51K.
Teva Pharmaceuticals made up 0.09% of IFP Advisors's portfolio in Q2 2026, its #257 holding.
IFP Advisors first reported a position in Teva Pharmaceuticals in Q4 2015 and has held it in 42 quarters since.
141 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.